Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by 3dollaron Apr 13, 2009 2:24pm
353 Views
Post# 15913951

RE: Good Point Watchman -----------------------

RE: Good Point Watchman -----------------------
Maybe I am missing something here but the majority of you are suggesting that there is new dilution going on????  These warrants were all granted in the past and now the company is simply trying to get them off the books for a number of reasons.....if this company is ever going to see a $1+ like many of us have suggested then all of the outstanding warrants will get exercised.  Anyone who does not believe that our actual float is more like 470m shares outstanding is fooling themselves.  The only point of contention I can see is giving the warrant holders a break on the deal they struck in the past.  As a one off just prior to FDA response I don't have a problem with it........if it continues as a trend then i think it is completely unfair to the rest of us who buy on the open market in good faith and also suggests that perhaps FDA is not as certain as we would all like to believe.

Lastly, this notion of voting down the warrant plan for the upcoming year seems short sighted.  You didn't vote down last year and or in any prior years??  Management simply wants the same thing the shareholders have given them in the past.  If it is granted and they exercise the option prior to a response from FDA then it sucks to be us.  I'm with Watchman on this....let's all try and remain calm and remind ourselves that none of us (or at least no one credible) have a clue as to what is involved when dealing with FDA and the intricacies of negotiating a multi million dollar deal with a large pharma who in reality holds all of the cards at the table.
Bullboard Posts